Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy Article Early Access

cited authors

  • Yardley, Denise A.; Peacock, Nancy; Daniel, Brooke; Anz, Betrand; Molthrop, David C., Jr.; Shroff, Sonalee K.; Young, Robyn; Jankov, Aleksander; Vander Woude, Amy; Shastry, Mythili; Pasek, Johanna; DeBusk, Laura M.; Hainsworth, John D.

Publication Date

  • February 14, 2020

webpage

published in

category

keywords

  • Adjuvant therapy
  • Eribulin
  • Neoadjuvant therapy

start page

  • 647

end page

  • 655

volume

  • 180

issue

  • 3